- Home
- COEP vs DSS Comparison
COEP vs DSS Comparison
Compare COEP & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- DSS
- Stock Information
- Founded
- COEP 2017
- DSS 1984
- Country
- COEP United States
- DSS United States
- Employees
- COEP N/A
- DSS N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- DSS Containers/Packaging
- Sector
- COEP Health Care
- DSS Consumer Discretionary
- Exchange
- COEP Nasdaq
- DSS Nasdaq
- Market Cap
- COEP 8.1M
- DSS 9.1M
- IPO Year
- COEP N/A
- DSS N/A
- Fundamental
- Price
- COEP $0.21
- DSS $1.10
- Analyst Decision
- COEP
- DSS
- Analyst Count
- COEP 0
- DSS 0
- Target Price
- COEP N/A
- DSS N/A
- AVG Volume (30 Days)
- COEP 282.8K
- DSS 25.4K
- Earning Date
- COEP 11-13-2024
- DSS 11-13-2024
- Dividend Yield
- COEP N/A
- DSS N/A
- EPS Growth
- COEP N/A
- DSS N/A
- EPS
- COEP N/A
- DSS N/A
- Revenue
- COEP N/A
- DSS $19,276,000.00
- Revenue This Year
- COEP N/A
- DSS N/A
- Revenue Next Year
- COEP N/A
- DSS N/A
- P/E Ratio
- COEP N/A
- DSS N/A
- Revenue Growth
- COEP N/A
- DSS N/A
- 52 Week Low
- COEP $0.15
- DSS $1.05
- 52 Week High
- COEP $1.33
- DSS $3.46
- Technical
- Relative Strength Index (RSI)
- COEP 50.31
- DSS 38.87
- Support Level
- COEP $0.19
- DSS $1.05
- Resistance Level
- COEP $0.22
- DSS $1.18
- Average True Range (ATR)
- COEP 0.02
- DSS 0.07
- MACD
- COEP -0.00
- DSS -0.02
- Stochastic Oscillator
- COEP 46.15
- DSS 20.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.